 BOSTON, March 02, 2021 GLOBE NEWSWIRE -- Yumanity Therapeutics Nasdaq: YMTX, a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced that Richard Peters, M.D., Ph.D., President and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference. 